Next Article in Journal
Glutamine Synthetase 1 Increases Autophagy Lysosomal Degradation of Mutant Huntingtin Aggregates in Neurons, Ameliorating Motility in a Drosophila Model for Huntington’s Disease
Next Article in Special Issue
Comment on: “Mitochondrial Mechanisms of Neuromuscular Junction Degeneration with Aging. Cells 2020, 9, 197”
Previous Article in Journal
Hypoxia-Inducible Factor-1α: The Master Regulator of Endothelial Cell Senescence in Vascular Aging
Previous Article in Special Issue
Glutamate at the Vertebrate Neuromuscular Junction: From Modulation to Neurotransmission
Comment published on 29 July 2020, see Cells 2020, 9(8), 1796.
Review

Mitochondrial Mechanisms of Neuromuscular Junction Degeneration with Aging

Department of Physical Therapy and Department of Physiology & Functional Genomics, University of Florida, Gainesville, FL 32608, USA
*
Author to whom correspondence should be addressed.
Cells 2020, 9(1), 197; https://doi.org/10.3390/cells9010197
Received: 22 November 2019 / Revised: 7 January 2020 / Accepted: 8 January 2020 / Published: 13 January 2020
Skeletal muscle deteriorates with aging, contributing to physical frailty, poor health outcomes, and increased risk of mortality. Denervation is a major driver of changes in aging muscle. This occurs through transient denervation-reinnervation events throughout the aging process that remodel the spatial domain of motor units and alter fiber type. In advanced age, reinnervation wanes, leading to persistent denervation that accelerates muscle atrophy and impaired muscle contractility. Alterations in the muscle fibers and motoneurons are both likely involved in driving denervation through destabilization of the neuromuscular junction. In this respect, mitochondria are implicated in aging and age-related neurodegenerative disorders, and are also likely key to aging muscle changes through their direct effects in muscle fibers and through secondary effects mediated by mitochondrial impairments in motoneurons. Indeed, the large abundance of mitochondria in muscle fibers and motoneurons, that are further concentrated on both sides of the neuromuscular junction, likely renders the neuromuscular junction especially vulnerable to age-related mitochondrial dysfunction. Manifestations of mitochondrial dysfunction with aging include impaired respiratory function, elevated reactive oxygen species production, and increased susceptibility to permeability transition, contributing to reduced ATP generating capacity, oxidative damage, and apoptotic signaling, respectively. Using this framework, in this review we summarize our current knowledge, and relevant gaps, concerning the potential impact of mitochondrial impairment on the aging neuromuscular junction, and the mechanisms involved. View Full-Text
Keywords: neuromuscular junction; aging; muscle atrophy; mitochondria; motoneuron; skeletal muscle neuromuscular junction; aging; muscle atrophy; mitochondria; motoneuron; skeletal muscle
Show Figures

Graphical abstract

MDPI and ACS Style

Anagnostou, M.-E.; Hepple, R.T. Mitochondrial Mechanisms of Neuromuscular Junction Degeneration with Aging. Cells 2020, 9, 197. https://doi.org/10.3390/cells9010197

AMA Style

Anagnostou M-E, Hepple RT. Mitochondrial Mechanisms of Neuromuscular Junction Degeneration with Aging. Cells. 2020; 9(1):197. https://doi.org/10.3390/cells9010197

Chicago/Turabian Style

Anagnostou, Maria-Eleni; Hepple, Russell T. 2020. "Mitochondrial Mechanisms of Neuromuscular Junction Degeneration with Aging" Cells 9, no. 1: 197. https://doi.org/10.3390/cells9010197

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop